このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Advanced Health Intelligence 将来の成長

Future 基準チェック /56

Advanced Health Intelligence収益と収益がそれぞれ年間178.9%と166.6%増加すると予測されています。

主要情報

178.9%

収益成長率

n/a

EPS成長率

Healthcare Services 収益成長	21.4%
収益成長率	166.6%
将来の株主資本利益率	n/a
アナリストカバレッジ	Low
最終更新日	02 Oct 2023

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

ASX:AHI - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2025	40	13	N/A	N/A	1
6/30/2024	9	-2	N/A	N/A	1
12/31/2023	-1	-17	-8	-8	N/A
9/30/2023	0	-15	-8	-8	N/A
6/30/2023	1	-13	-7	-7	N/A
3/31/2023	2	-11	-9	-9	N/A
12/31/2022	2	-10	-11	-11	N/A
9/30/2022	1	-15	-10	-10	N/A
6/30/2022	0	-20	-10	-10	N/A
3/31/2022	0	-22	-8	-8	N/A
12/31/2021	0	-23	-7	-6	N/A
9/30/2021	0	-19	-5	-5	N/A
6/30/2021	1	-14	-4	-4	N/A
3/31/2021	1	-11	-3	-3	N/A
12/31/2020	1	-8	-2	-2	N/A
9/30/2020	1	-7	-3	-2	N/A
6/30/2020	0	-5	-3	-3	N/A
3/31/2020	0	-5	-3	-3	N/A
12/31/2019	0	-5	-4	-4	N/A
9/30/2019	0	-5	-4	-4	N/A
6/30/2019	0	-4	-3	-3	N/A
3/31/2019	0	-4	-3	-3	N/A
12/31/2018	0	-4	-3	-3	N/A
9/30/2018	1	-9	-2	-2	N/A
6/30/2018	2	-14	-1	-1	N/A
3/31/2018	2	-14	-1	-1	N/A
12/31/2017	2	-13	-1	-1	N/A
9/30/2017	1	-8	N/A	-1	N/A
6/30/2017	0	-2	N/A	-2	N/A
3/31/2017	0	-2	N/A	-2	N/A
12/31/2016	0	-2	N/A	-2	N/A
9/30/2016	0	-2	N/A	-2	N/A
6/30/2016	N/A	-2	N/A	-2	N/A
6/30/2015	0	-1	N/A	-1	N/A

アナリストによる今後の成長予測

収入対貯蓄率: AHIは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.2% ) よりも高い成長率であると考えられます。

収益対市場: AHI今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: AHI今後 3 年以内に収益を上げることが予想されます。

収益対市場: AHIの収益 ( 166.6% ) Australian市場 ( 5.2% ) よりも速いペースで成長すると予測されています。

高い収益成長: AHIの収益 ( 166.6% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: AHIの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Advanced Health Intelligence 将来の成長

Future 基準チェック /56

主要情報

今後の成長に関する最新情報

Forecast breakeven date pushed back to 2025

Forecast breakeven date pushed back to 2025

Forecast to breakeven in 2023

Recent updates

Advanced Health Intelligence Ltd(NasdaqCM:AHI) dropped from NASDAQ Composite Index

Advanced Health Intelligence Ltd has filed a Follow-on Equity Offering in the amount of AUD 1.9575 million.

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.2 million.

Advanced Health Intelligence Ltd to Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. announced delayed 20-F filing

Advanced Health Intelligence Ltd., Annual General Meeting, Nov 17, 2023

Advanced Health Intelligence Ltd. announced that it has received AUD 1.5 million in funding

Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.13 loss in FY 2022)

New minor risk - Financial data availability

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 5 million.

New major risk - Share price stability

First half 2023 earnings released: AU$0.024 loss per share (vs AU$0.10 loss in 1H 2022)

Forecast breakeven date pushed back to 2025

High number of new directors

Advanced Health Intelligence Ltd. Announces Board Changes

Advanced Human Imaging Limited (ASX:AHI) completed the acquisition of WellteQ Digital Health Inc. (CNSX:WTEQ).

Advanced Human Imaging Appoints Dr. Peter Vaughan as Non-Executive Director

Advanced Human Imaging Limited announced delayed 20-F filing

Advanced Human Imaging Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.11 loss in FY 2021)

Forecast breakeven date pushed back to 2025

Full year 2022 earnings released: AU$0.13 loss per share (vs AU$0.11 loss in FY 2021)

Advanced Human Imaging Limited (ASX:AHI) executed a non-binding letter of intent to acquire WellteQ Digital Health Inc. (CNSX:WTEQ) for AUD 4.3 million.

Advanced Human Imaging Ltd Appoints Peter Goldstein as Non-Executive Director

Advanced Human Imaging Limited to Be Deleted from Other OTC

Advanced Human Imaging Limited Announces Resignation of Edward Greissing Jr as Director

Does Advanced Human Imaging (ASX:AHI) Have A Healthy Balance Sheet?

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Forecast to breakeven in 2023

Advanced Human Imaging Limited Appoints Dr. Katherine Iscoe as Director

Advanced Human Imaging Limited Announces Executive Changes

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces the Submission of the Health Cube App into the Top 10 China App Stores with Tinjoy Biotech Limited

No independent directors

No independent directors

No independent directors

No independent directors

No independent directors

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces Derma AI Embedded in the AHI DermaScan Receives CE Mark Clearance in the European Union for the Dermatology AI Component in CompleteScan

Advanced Human Imaging's DermaScan AI Receives Medical Device Approval 27 EU Countries (CE Mark)

Advanced Human Imaging Limited to Launch BodyScan in Original Fit Factory's Fitness App Truconnect to Audience of 150+ Million

Advanced Human Imaging (ASX:AHI) Has Debt But No Earnings; Should You Worry?

New 90-day high: AU$2.17

First half 2021 earnings released: AU$0.046 loss per share (vs AU$0.029 loss in 1H 2020)

What We Learned About MyFiziq's (ASX:MYQ) CEO Compensation

MyFiziq Limited to Appoint New US Board Members in Readiness for Nasdaq

MyFiziq Names William Bradford as New Global Chief Business Officer in USA

New 90-day high: AU$1.35

How Many MyFiziq Limited (ASX:MYQ) Shares Have Insiders Sold, In The Last Year?

MyFiziq Signs Marketing and Expansion Agreement with Bearn

MyFiziq Limited Announces Management Changes

Myfiziq Limited Releases Applications with Biomorphik Pty Ltd App with the Myfiziq Technology

Do Insiders Own Lots Of Shares In MyFiziq Limited (ASX:MYQ)?

MyFiziq Limited Completes Definitive Agreements with MVMNT Inc

MyFiziq Limited announced that it expects to receive AUD 5 million in funding

MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited

Myfiziq Limited Signs Agreement with Nexus-Vita with USD 3.5 Million Guarantee

MyFiziq Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.052 loss per share

New 90-day high: AU$1.32

MyFiziq Limited Signs Definitive Agreements with Biomorphik to Accelerate A November 2020 Release

New 90-day high - AU$0.61

Full year earnings released - AU$0.052 loss per share

New 90-day high - AU$0.32

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘